<abstract xmlns="http://www.w3.org/1999/xhtml"><sec id="j_joepi-2016-0006_s_001"><h3>Background</h3><p>Valproic acid (VPA) is a wide-spectrum antiepileptic drug used both in children and in adults. We describe a clinically important interaction between VPA and imipenem, a carbapenem antimicrobial.</p></sec><sec id="j_joepi-2016-0006_s_002"><h3>Case presentation</h3><p>Our patient was a 19-year-old man with childhood onset of mental retardation and severe epilepsy. He was hospitalized due to pneumonia. His antiepileptic drugs, including VPA, were administered intravenously. Due to pneumonia, intravenously administered imipenem was started. After the start of imipenem treatment, a dramatic decrease in the plasma concentrations of VPA occurred within 24 hours. After the discontinuation of imipenem treatment, the concentration of VPA recovered within a few hours. The decrease in VPA levels was associated with increased seizure frequency.</p></sec><sec id="j_joepi-2016-0006_s_003"><h3>Conclusions</h3><p>The time course of the VPA–imipenem interaction suggests that mechanisms other than a change in the enzymatic elimination of VPA is the cause for this pharmacokinetic interaction. Concomitant use of VPA and imipenem should be avoided.</p></sec></abstract>

BackgroundValproic acid (VPA) is a wide-spectrum antiepileptic drug used both in children and in adults. We describe a clinically important interaction between VPA and imipenem, a carbapenem antimicrobial.Case presentationOur patient was a 19-year-old man with childhood onset of mental retardation and severe epilepsy. He was hospitalized due to pneumonia. His antiepileptic drugs, including VPA, were administered intravenously. Due to pneumonia, intravenously administered imipenem was started. After the start of imipenem treatment, a dramatic decrease in the plasma concentrations of VPA occurred within 24 hours. After the discontinuation of imipenem treatment, the concentration of VPA recovered within a few hours. The decrease in VPA levels was associated with increased seizure frequency.ConclusionsThe time course of the VPA–imipenem interaction suggests that mechanisms other than a change in the enzymatic elimination of VPA is the cause for this pharmacokinetic interaction. Concomitant use of VPA and imipenem should be avoided.

Concomitant treatment with imipenem causes a rapid and extensive decrease in the plasma concentrations of valproic acid

Journal of Epileptology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

BackgroundValproic acid (VPA) is a wide-spectrum antiepileptic drug used both in children and in adults. We describe a clinically important interaction between...

Concomitant treatment with imipenem causes a rapid and extensive decrease in the plasma concentrations of valproic acid

Pubblicato online: 15 giu 2016

Pagine: 63 - 66

Ricevuto: 07 apr 2016

Accettato: 14 giu 2016

DOI: https://doi.org/10.21307/joepi-2016-0006

Parole chiave
valproic acid, carbapenems, imipenem, interaction, epilepsy

© 2016 Tapani Keränen et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Concomitant treatment with imipenem causes a rapid and extensive decrease in the plasma concentrations of valproic acid

Pubblicato online: 15 giu 2016

Pagine: 63 - 66

Ricevuto: 07 apr 2016

Accettato: 14 giu 2016

DOI: https://doi.org/10.21307/joepi-2016-0006

Parole chiavevalproic acid, carbapenems, imipenem, interaction, epilepsy

© 2016 Tapani Keränen et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Parole chiave
valproic acid, carbapenems, imipenem, interaction, epilepsy